CIA
FATE icon

Capital Impact Advisors’s Fate Therapeutics FATE Stock Holding History

Capital Impact Advisors’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-45,738
Closed -$218K – 131
2023
Q2 		$218K Buy
45,738
+4,421
+11% +$24.4K 0.24% 153
2023
Q1 		$236K Buy
41,317
+22,860
+124% +$138K 0.29% 143
2022
Q4 		$186K Sell
18,457
-1,816
-9% -$34.1K 0.18% 191
2022
Q3 		$408K Buy
20,273
+3,747
+23% +$108K 0.41% 100
2022
Q2 		$410K Sell
16,526
-2,323
-12% -$64.1K 0.38% 122
2022
Q1 		$731K Buy
18,849
+8,649
+85% +$335K 0.53% 84
2021
Q4 		$597K Buy
+10,200
New +$578K 0.41% 74
2021
Q1 		– Sell
-32,000
Closed -$2.91M – 117
2020
Q4 		$2.91M Buy
+32,000
New +$1.99M 0.71% 61

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return